Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient

Pediatric Blood and Cancer

Volumn 51, Issue 4, 2008, Pages 568-

  Bhat, Priya ^a   Sisler, India ^b   Collier III, Anderson B ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; METHEMOGLOBIN; METHYLENE BLUE; RASBURICASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; CASE REPORT; EXCHANGE BLOOD TRANSFUSION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOLYSIS; HEMOLYTIC ANEMIA; HIGH RISK PATIENT; HUMAN; LETTER; MALE; METHEMOGLOBINEMIA; OXYGEN SATURATION; PRIORITY JOURNAL; SCHOOL CHILD; T CELL LEUKEMIA; TREATMENT INDICATION; TREATMENT OUTCOME;

BLOOD TRANSFUSION; CHILD; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; MALE; METHEMOGLOBINEMIA; URATE OXIDASE;

EID: 50249146741     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21582     Document Type: Letter

References (4)

1. Borinstein SC, Xu M, Hawkins DS. Methemoglobinemia and, hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma/leukemia. Pediatr Blood Cancer 2008;50:189.
2. Mansouri A, Lurie AA. Concise review: Methemoglobinemia. Am J Hematol 1993;42:7-712.
3. Rosen PJ, Johnson C, McGehee WG, et al. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med 1971;75:83-86.
4. Golden PJ, Weinstein R. Treatment of high-risk, refractory acquired methemoglobinemia with automated red blood cell exchange. J Clin Apheresis 1998;13:28-31.